NCT02004379已完成不适用
Register of Telaprevir and Boceprevir in Routine Clinical Practice
Fundación Pública Andaluza Progreso y Salud47 个研究点 分布在 1 个国家目标入组 1,553 人开始时间: 2013年11月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,553
- 试验地点
- 47
- 主要终点
- Safety of current treatment of hepatitis C virus, genotype 1, for patients who have never been treated and for patients who have been previously treated
研究概览
简要总结
Know through routine clinical practice the effectiveness and safety of current treatment of hepatitis C virus, genotype 1, for patients who have never been treated and for patients who have been previously treated
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients infected by hepatitis C virus, genotype 1
- •Indication of treatment with telaprevir or boceprevir in F3 and F4 fibrosis
排除标准
- •Being taking part in other
- •Inability to follow a monitoring
- •Contra-indications on triple therapy
- •Coinfected with HIV and HBV (hepatitis B virus)
结局指标
主要结局
Safety of current treatment of hepatitis C virus, genotype 1, for patients who have never been treated and for patients who have been previously treated
时间窗: 12 months
Number and frequencies of serious adverse event (SAE) during the treatment
Effectiveness of current treatment of hepatitis C virus, genotype 1, for patients who have never been treated and for patients who have been previously treated
时间窗: 12 months
Know through routine clinical practice the percentage of patients who have negative VHC-ARN
次要结局
未报告次要终点
研究者
研究点 (47)
Loading locations...
相似试验
终止
3 期
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)InfectionNCT01821963M.D. Anderson Cancer Center1
已完成
3 期
Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination TherapyHepatitis C, ChronicNCT02060058Kaohsiung Medical University Chung-Ho Memorial Hospital12
Unknown
2 期
Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis PatientsChronic Hepatitis cNCT03067883Ain Shams University40
已完成
3 期
Safety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755)Hepatitis C, ChronicNCT01544920Merck Sharp & Dohme LLC737
已完成
4 期
Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis BNon Hodgkin's LymphomaHepatitis BNCT00926757Taipei Veterans General Hospital, Taiwan80